192 related articles for article (PubMed ID: 27869573)
1. The chemokine, CXCL16, and its receptor, CXCR6, are constitutively expressed in human annulus fibrosus and expression of CXCL16 is up-regulated by exposure to IL-1ß in vitro.
Gruber HE; Marrero E; Ingram JA; Hoelscher GL; Hanley EN
Biotech Histochem; 2017; 92(1):7-14. PubMed ID: 27869573
[TBL] [Abstract][Full Text] [Related]
2. CXCL16 functions as a novel chemotactic factor for prostate cancer cells in vitro.
Lu Y; Wang J; Xu Y; Koch AE; Cai Z; Chen X; Galson DL; Taichman RS; Zhang J
Mol Cancer Res; 2008 Apr; 6(4):546-54. PubMed ID: 18344492
[TBL] [Abstract][Full Text] [Related]
3. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
4. Activation of the CXCL16/CXCR6 Pathway by Inflammation Contributes to Atherosclerosis in Patients with End-stage Renal Disease.
Hu ZB; Chen Y; Gong YX; Gao M; Zhang Y; Wang GH; Tang RN; Liu H; Liu BC; Ma KL
Int J Med Sci; 2016; 13(11):858-867. PubMed ID: 27877078
[No Abstract] [Full Text] [Related]
5. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
[TBL] [Abstract][Full Text] [Related]
6. Associations of CXCL16/CXCR6 with carotid atherosclerosis in patients with metabolic syndrome.
Lv Y; Hou X; Ti Y; Bu P
Clin Nutr; 2013 Oct; 32(5):849-54. PubMed ID: 23398954
[TBL] [Abstract][Full Text] [Related]
7. CXCR6-CXCL16 axis promotes prostate cancer by mediating cytoskeleton rearrangement via Ezrin activation and αvβ3 integrin clustering.
Singh R; Kapur N; Mir H; Singh N; Lillard JW; Singh S
Oncotarget; 2016 Feb; 7(6):7343-53. PubMed ID: 26799186
[TBL] [Abstract][Full Text] [Related]
8. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
Hu W; Liu Y; Zhou W; Si L; Ren L
PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301
[TBL] [Abstract][Full Text] [Related]
9. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Escherichia coli in pathogenesis of xanthogranulomatous cholecystitis with scavenger receptor class A and CXCL16-CXCR6 interaction.
Sawada S; Harada K; Isse K; Sato Y; Sasaki M; Kaizaki Y; Nakanuma Y
Pathol Int; 2007 Oct; 57(10):652-63. PubMed ID: 17803654
[TBL] [Abstract][Full Text] [Related]
11. Expression and localization of CXCL16 and CXCR6 in ovarian endometriotic tissues.
Manabe S; Iwase A; Goto M; Kobayashi H; Takikawa S; Nagatomo Y; Nakahara T; Bayasula ; Nakamura T; Hirokawa W; Kikkawa F
Arch Gynecol Obstet; 2011 Dec; 284(6):1567-72. PubMed ID: 21773780
[TBL] [Abstract][Full Text] [Related]
12. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
Guo L; Cui ZM; Zhang J; Huang Y
Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
[TBL] [Abstract][Full Text] [Related]
13. The transmembrane chemokines CXCL16 and CX3CL1 and their receptors are expressed in human meningiomas.
Li G; Hattermann K; Mentlein R; Mehdorn HM; Held-Feindt J
Oncol Rep; 2013 Feb; 29(2):563-70. PubMed ID: 23229614
[TBL] [Abstract][Full Text] [Related]
14. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
[TBL] [Abstract][Full Text] [Related]
15. Expression of serglycin in human disc is increased in degenerated discs and up-regulated in vitro by exposure to IL-1ß or TNF-α.
Gruber HE; Hanley EN
Biotech Histochem; 2018; 93(2):109-117. PubMed ID: 29319363
[TBL] [Abstract][Full Text] [Related]
16. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer].
Zhou WH; Hu WD; Wu ZQ; Zheng XM; Wang BC
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):947-51. PubMed ID: 20646641
[TBL] [Abstract][Full Text] [Related]
17. The CXCL16 A181V mutation selectively inhibits monocyte adhesion to CXCR6 but is not associated with human coronary heart disease.
Petit SJ; Wise EL; Chambers JC; Sehmi J; Chayen NE; Kooner JS; Pease JE
Arterioscler Thromb Vasc Biol; 2011 Apr; 31(4):914-20. PubMed ID: 21233446
[TBL] [Abstract][Full Text] [Related]
18. The CXCL16-CXCR6 chemokine axis in glial tumors.
Hattermann K; Held-Feindt J; Ludwig A; Mentlein R
J Neuroimmunol; 2013 Jul; 260(1-2):47-54. PubMed ID: 23628207
[TBL] [Abstract][Full Text] [Related]
19. Expression and potential function of the CXC chemokine CXCL16 in pancreatic ductal adenocarcinoma.
Wente MN; Gaida MM; Mayer C; Michalski CW; Haag N; Giese T; Felix K; Bergmann F; Giese NA; Friess H
Int J Oncol; 2008 Aug; 33(2):297-308. PubMed ID: 18636150
[TBL] [Abstract][Full Text] [Related]
20. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
